. Author manuscript; available in PMC: 2008 Sep 1.

Published in final edited form as: Psychoneuroendocrinology. 2007 Jul 30;32(8-10):951–958. doi: 10.1016/j.psyneuen.2007.06.014

Table 2.

Age-adjusted and multivariate-adjusted OR of having depressive symptoms (CES-D ≥16) according to categories of total and bioavailable testosterone and CAG repeat length for black and white men in CARDIA Male Hormone Study (1995–1996).

	Black men					White men
	Age-adjusted			Multivariate-adjusted^a		Age-adjusted			Multivariate-adjusted^a

	Cases/ total N	OR	(95% CI)	OR	(95% CI)	Cases/ total N	OR	(95% CI)	OR	(95% CI)
Quartiles of total T (ng/ml)
Q1: ≤4.42	31/128	1.00		1.00		24/183	1.00		1.00
Q2: 4.43–5.54	22/125	0.67	(0.36–1.23)	0.52	(0.27–0.98)	20/184	0.83	(0.44–1.56)	0.82	(0.43–1.56)
Q3: 5.55–6.72	25/132	0.73	(0.40–1.32)	0.48	(0.25–0.91)	29/183	1.30	(0.72–2.34)	1.27	(0.69–2.33)
Q4: ≥ 6.73	32/140	0.92	(0.52–1.63)	0.56	(0.29–1.06)	18/171	0.81	(0.42–1.55)	0.74	(0.37–1.48)
Quartiles of bioavailable T (ng/ml)
Q1: ≤ 2.20	31/130	1.00		1.00		16/181	1.00		1.00
Q2: 2.21–2.74	24/119	0.81	(0.44–1.47)	0.64	(0.34–1.21)	24/192	1.49	(0.77–2.92)	1.47	(0.75–2.89)
Q3: 2.75–3.39	24/120	0.79	(0.43–1.45)	0.60	(0.32–1.13)	32/191	2.16	(1.14–4.10)	2.19	(1.15–4.18)
Q4: ≥ 3.40	31/156	0.78	0(.44–1.38)	0.58	(0.32–1.06)	19/157	1.52	(0.75–3.10)	1.50	(0.73–3.06)
Tertiles of CAG RL
T1: ≤ 18	46/251	1.00		1.00		17/151	1.00		1.00
T2: 19–21	45/171	1.59	(1.00–2.54)	1.66	(1.02–2.68)	38/279	1.24	(0.67–2.28)	1.23	(0.67–2.28)
T3: 22+	19/103	1.01	(0.56–1.82)	1.07	(0.59–1.96)	36/291	1.10	(0.60–2.04)	1.11	(0.60–2.06)

Adjusted for age, body mass index, cigarettes/d, alcohol consumption (ml/d), and total physical activity score.

OR, odds ratio, CES-D, Center for Epidemiologic Studies Depression Scale, CARDIA, Coronary Artery Risk Development in Young Adults, CI, confidence interval.